Advances in the treatment of non-Hodgkin's lymphoma

被引:9
作者
Cerny, T [1 ]
Gillessen, S [1 ]
机构
[1] Kantonsspital St Gallen, Dept Internal Med, Div Hematol & Oncol, St Gallen, Switzerland
关键词
D O I
10.1093/annonc/mdf662
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:211 / 216
页数:6
相关论文
共 34 条
  • [1] RETRACTED: High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support - Results of a pilot study (Retracted Article)
    Behr, TM
    Griesinger, F
    Riggert, J
    Gratz, S
    Béhé, M
    Kaufmann, CC
    Wörmann, B
    Brittinger, G
    Becker, W
    [J]. CANCER, 2002, 94 (04) : 1363 - 1372
  • [2] Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
    Bertoni, F
    Conconi, A
    Capella, C
    Motta, T
    Giardini, R
    Ponzoni, M
    Pedrinis, E
    Novero, D
    Rinaldi, P
    Cazzaniga, G
    Biondi, A
    Wotherspoon, A
    Hancock, BW
    Smith, P
    Souhami, R
    Cotter, FE
    Cavalli, F
    Zucca, E
    [J]. BLOOD, 2002, 99 (07) : 2541 - 2544
  • [3] BONNET C, 2002, ANN ONCOL S2, V13, P79
  • [4] BREDENFELD H, 2002, ANN ONCOL S2, V13, P212
  • [5] Cerny T, 2000, ANN ONCOL, V11, P117
  • [6] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier, B
    Lepage, E
    Brière, J
    Herbrecht, R
    Tilly, H
    Bouabdallah, R
    Morel, P
    Van den Neste, E
    Salles, G
    Gaulard, P
    Reyes, F
    Gisselbrecht, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242
  • [7] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation
    Colombat, P
    Salles, G
    Brousse, N
    Eftekhari, P
    Soubeyran, P
    Delwail, V
    Deconinck, E
    Haïoun, C
    Foussard, C
    Sebban, C
    Stamatoullas, A
    Milpied, N
    Boué, F
    Taillan, B
    Lederlin, P
    Najman, A
    Thièblemont, C
    Montestruc, F
    Mathieu-Boué, A
    Benzohra, A
    Solal-Céligny, P
    [J]. BLOOD, 2001, 97 (01) : 101 - 106
  • [8] Rituximab in combination with CHOP or fludarabine in low-grade lymphoma
    Czuczman, MS
    Fallon, A
    Mohr, A
    Stewart, C
    Bernstein, ZP
    McCarthy, P
    Skipper, M
    Brown, K
    Miller, K
    Wentling, D
    Klippenstein, D
    Loud, P
    Rock, MK
    Benyunes, M
    Grillo-López, AJ
    Bernstein, SH
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 36 - 40
  • [9] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
    Czuczman, MS
    Grillo-López, AJ
    White, CA
    Saleh, M
    Gordon, L
    LoBuglio, AF
    Jonas, C
    Klippenstein, D
    Dallaire, B
    Varns, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
  • [10] Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma:: Results of a phase II trial of rituximab
    Davis, TA
    White, CA
    Grillo-López, AJ
    Velásquez, WS
    Link, B
    Maloney, DG
    Dillman, RO
    Williams, ME
    Mohrbacher, A
    Weaver, R
    Dowden, S
    Levy, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1851 - 1857